Comparative proteomic analysis of human amniotic fluid supernatants with down syndrome using mass spectrometry

Journal of Microbiology and Biotechnology

Volumn 20, Issue 6, 2010, Pages 959-967

  Park, Jisook ^a   Cha, Dong Hyun ^b   Jung, Jin Woo ^a   Kim, Young Hwan ^c,d   Lee, Sook Hwan ^b   Kim, Young Jun ^e   Kim, Kwang Pyo ^a  

^a Konkuk University   (South Korea)

^b CHA University   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d Chungnam National University   (South Korea)

^e Konkuk University   (South Korea)

Author keywords

Amniotic fluid; Biomarker; Down syndrome; Liquid chromatography electrospray ionization mass spectrometry; Proteomics

Indexed keywords

ALPHA FETOPROTEIN; APOLIPOPROTEIN A2; PROTEIN;

AFFINITY CHROMATOGRAPHY; AMNION FLUID ANALYSIS; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; DOWN SYNDROME; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FETUS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PREGNANCY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; UPREGULATION; AMNION FLUID; CHEMISTRY; COMPARATIVE STUDY; GENETICS; METABOLISM; MOLECULAR GENETICS; PRENATAL DIAGNOSIS; PROCEDURES;

AMNIOTIC FLUID; DOWN SYNDROME; FEMALE; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PREGNANCY; PRENATAL DIAGNOSIS; PROTEINS; PROTEOMICS;

EID: 77954961914     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0912.12035     Document Type: Article

References (52)

1. Aebersold, R. and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422: 198-207.
2. Ahn, Y. H., E. S. Ji, J. Y. Lee, K. Cho, and J. S. Yoo. 2007. Coupling of TiO(2)-mediated enrichment and on-bead guanidinoethanethiol labeling for effective phosphopeptide analysis by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 21: 3987-3994.
3. Antonarakis, S. E., R. Lyle, E. T. Dermitzakis, A. Reymond, and S. Deutsch. 2004. Chromosome 21 and Down syndrome: From genomics to pathophysiology. Nat. Rev. Genet. 5: 725-738.
4. Benn, P. A., J. Ying, T. Beazoglou, and J. F. Egan. 2001. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Prenat. Diagn. 21: 46-51.
5. Bobrow, M., T. Barby, A. Hajianpour, D. Maxwell, and S. C. Yau. 1992. Fertility in a male with trisomy 21. J. Med. Genet. 29: 141.
6. Buhimschi, C. S., V. Bhandari, B. D. Hamar, M. O. Bahtiyar, G. Zhao, A. K. Sfakianaki, et al. 2007. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 4: e18.
7. Buhimschi, I. A., E. Zambrano, C. M. Pettker, M. O. Bahtiyar, M. Paidas, V. A. Rosenberg, S. Thung, C. M. Salafia, and C. S. Buhimschi. 2008. Using proteomic analysis of the human amniotic fluid to identify histologic chorioamnionitis. Obstet. Gynecol. 111: 403-412.
8. Christiansen, M., I. Jaliashvili, M. T. Overgaard, C. Ensinger, P. Obrist, and C. Oxvig. 2000. Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin. Chem. 46: 1099-1105.
9. Fountoulakis, M. 2001. Proteomics: Current technologies and applications in neurological disorders and toxicology. Amino Acids 21: 363-381.
10. Freidl, M., T. Gulesserian, G. Lubec, M. Fountoulakis, and B. Lubec. 2001. Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down syndrome. J. Neural Transm. Suppl. 61: 47-57.
11. Friberg, H. and T. Wieloch. 2002. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84: 241-250.
12. Gupta, M. K., J. M. Jang, J. W. Jung, S. J. Uhm, K. P. Kim, and H. T. Lee. 2009. Proteomic analysis of parthenogenetic and in vitro fertilized porcine embryos. Proteomics 9: 2846-2860.
13. Hassan, M. I., V. Kumar, T. P. Singh, and S. Yadav. 2008. Proteomic analysis of human amniotic fluid from Rh(-) pregnancy. Prenat. Diagn. 28: 102-108.
14. Hassell, J. R., J. H. Kimura, and V. C. Hascall. 1986. Proteoglycan core protein families. Annu. Rev. Biochem. 55: 539-567.
15. Hook, E. B. and A. Lindsjo. 1978. Down syndrome in live births by single year maternal age interval in a Swedish study: Comparison with results from a New York State study. Am. J. Hum. Genet. 30: 19-27.
16. Hsiang, Y. H., G. D. Berkovitz, G. L. Bland, C. J. Migeon, and A. C. Warren. 1987. Gonadal function in patients with Down syndrome. Am. J. Med. Genet. 27: 449-458.
17. Huether, C. A., J. Ivanovich, B. S. Goodwin, E. L. Krivchenia, V. S. Hertzberg, L. D. Edmonds, D. S. May, and J. H. Priest. 1998. Maternal age specific risk rate estimates for Down syndrome among live births in whites and other races from Ohio and metropolitan Atlanta, 1970-1989. J. Med. Genet. 35: 482-490.
18. Kubota, T. and H. Takeuchi. 1998. Evaluation of insulin-like growth factor binding protein-1 as a diagnostic tool for rupture of the membranes. J. Obstet. Gynaecol. Res. 24: 411-417.
19. Langford, K., W. Blum, K. Nicolaides, J. Jones, A. McGregor, and J. Miell. 1994. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: A basis for programming by undernutrition? Eur J. Clin. Invest. 24: 851-856.
20. Lee, S. J., K. H. Kim, J. S. Park, J. W. Jung, Y. H. Kim, S. K. Kim, et al. 2007. Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines. Biochem. Biophys. Res. Commun. 357: 620-626.
21. Liberatori, S., L. Bini, C. De Felice, B. Magi, B. Marzocchi, R. Raggiaschi, et al. 1997. A two-dimensional protein map of human amniotic fluid at17 weeks' gestation. Electrophoresis 18: 2816-2822.
22. Lubec, G., K. Krapfenbauer, and M. Fountoulakis. 2003. Proteomics in brain research: Potentials and limitations. Prog. Neurobiol. 69: 193-211.
23. Mauk, M. R., F. I. Rosell, B. Lelj-Garolla, G. R. Moore, and A. G. Mauk. 2005. Metal ion binding to human hemopexin. Biochemistry 44: 1864-1871.
24. Mazurkiewicz, J. C., G F. Watts, F. G. Warburton, B. M. Slavin, C. Lowy, and E. Koukkou. 1994. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J. Clin. Pathol. 47: 728-731.
25. Michaels, J. E., S. Dasari, L. Pereira, A. P. Reddy, J. A. Lapidus, X. Lu, et al. 2007. Comprehensive proteomic analysis of the human amniotic fluid proteome: Gestational age-dependent changes. J. Proteome Res. 6: 1277-1285.
26. Michel, P. E., D. Crettaz, P. Morier, M. Heller, D. Gallot, J. D. Tissot, F. Reymond, and J. S. Rossier. 2006. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 27: 1169-1181.
27. Miell, J. P., K. S. Langford, J. S. Jones, P. Noble, M. Westwood, A. White, and K. H. Nicolaides. 1997. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: A possible diagnostic tool for trisomy 18 pregnancies. J. Clin. Endocrinol. Metab. 82: 287-292.
28. Nadesalingam, J., A. L. Bernal, A. W. Dodds, A. C. Willis, D. J. Mahoney, A. J. Day, K. B. Reid, and N. Palaniyar. 2003. Identification and characterization of a novel interaction between pulmonary surfactant protein D and decorin. J. Biol. Chem. 278: 25678-25687.
29. Nilsson, S., M. Ramstrom, M. Palmblad, O. Axelsson, and J. Bergquist. 2004. Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res. 3: 884-889.
30. Overgaard, M. T., E. S. Sorensen, D. Stachowiak, H. B. Boldt, L. Kristensen, L. Sottrup-Jensen, and C. Oxvig. 2003. Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment. J. Biol. Chem. 278: 2106-2117.
31. Park, S. J., W. G. Yoon, J. S. Song, H. S. Jung, C. J. Kim, S. Y. Oh, et al. 2006. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics 6: 349-363.
32. Pradhan, M., A. Dalal, F. Khan, and S. Agrawal. 2006. Fertility in men with Down syndrome: A case report. Fertil. Steril. 86: 1761-c1763.
33. Pulkkinen, L., T. Alitalo, T. Krusius, and L. Peltonen. 1992. Expression of decorin in human tissues and cell lines and defined chromosomal assignment of the gene locus (DCN). Cytogenet. Cell Genet. 60: 107-111.
34. Qian, W. J., T. Liu, M. E. Monroe, E. F. Strittmatter, J. M. Jacobs, L. J. Kangas, K. Petritis, D. G. Camp 2nd, and R. D. Smith. 2005. Probability-based evaluation of peptide and protein identifications from tandem mass spectrometry and SEQUEST analysis: The human proteome. J. Proteome Res. 4: 53-62.
35. Queloz, P. A., D. Crettaz, L. Thadikkaran, V. Sapin, D. Gallot, J. Jani, et al. 2007. Proteomic analyses of amniotic fluid: Potential applications in health and diseases. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 850: 336-342.
36. Roizen, N. J. and D. Patterson. 2003. Down's syndrome. Lancet 361: 1281-1289.
37. Rutanen, E. M., H. Bohn, and M. Seppala. 1982. Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am. J. Obstet. Gynecol. 144: 460-463.
38. Schonherr, E., M. Broszat, E. Brandan, P. Bruckner, and H. Kresse. 1998. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch. Biochem. Biophys. 355: 241-248.
39. Sheridan, R., J. Llerena Jr., S. Matkins, P. Debenham, A. Cawood, and M. Bobrow. 1989. Fertility in a male with trisomy 21. J. Med. Genet. 26: 294-298.
40. Smith, A. and W. T. Morgan. 1981. Hemopexin-mediated transport of heme into isolated rat hepatocytes. J. Biol. Chem. 256: 10902-10909.
41. Takahashi, N., Y. Takahashi, and F. W. Putnam. 1985. Complete amino acid sequence of human hemopexin, the heme-binding protein of serum. Proc. Natl. Acad. Sci. U.S.A. 82: 73-77.
42. Thadikkaran, L., D. Crettaz, M. A. Siegenthaler, D. Gallot, V. Sapin, R. V. Iozzo, P. A. Queloz, P. Schneider, and J. D. Tissot. 2005.The role of proteomics in the assessment of premature rupture of fetal membranes. Clin. Chim. Acta 360: 27-36.
43. Tsangaris, G. T., A. Kolialexi, P. M. Karamessinis, A. K. Anagnostopoulos, A. Antsaklis, M. Fountoulakis, and A. Mavrou. 2006. The normal human amniotic fluid supernatant proteome. In Vivo 20: 479-490.
44. Tsangaris, G. T., P. Karamessinis, A. Kolialexi, S. D. Garbis, A. Antsaklis, A. Mavrou, and M. Fountoulakis. 2006. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6: 4410-4419.
45. Uhm, S. J., M. K. Gupta, J. H. Yang, S. H. Lee, and H. T. Lee. 2007. Selenium improves the developmental ability and reduces the apoptosis in porcine parthenotes. Mol. Reprod. Dev. 74: 1386-1394.
46. Vascotto, C., A. M. Salzano, C. D'Ambrosio, A. Fruscalzo, D. Marchesoni, C. di Loreto, A. Scaloni, G. Tell, and F. Quadrifoglio. 2007. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J. Proteome Res. 6: 160-170.
47. Vuadens, F., C. Benay, D. Crettaz, D. Gallot, V. Sapin, P. Schneider, et al. 2003. Identification of biologic markers of the premature rupture of fetal membranes: Proteomic approach. Proteomics 3: 1521-1525.
48. Wald, N. J., H. S. Cuckle, J. W. Densem, K. Nanchahal, P. Royston, T. Chard, et al. 1988. Maternal serum screening for Down's syndrome in early pregnancy. Br. Med. J. 297: 883-887.
49. Wang, H. S., L. A. Perry, J. Kanisius, R. K. Iles, J. M. Holly, and T. Chard. 1991. Purification and assay of insulin-like growth factor-binding protein-1: Measurement of circulating levels throughout pregnancy. J. Endocrinol. 128: 161-168.
50. Xaus, J., M. Comalada, M. Cardo, A. F. Valledor, and A. Celada. 2001. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 98: 2124-2133.
51. Zolotarjova, N., J. Martosella, G. Nicol, J. Bailey, B. E. Boyes, and W. C. Barrett. 2005. Differences among techniques for high-abundant protein depletion. Proteomics 5: 3304-3313.
52. Zuhlke, C., U. Thies, I. Braulke, A. Reis, and C. Schirren. 1994. Down syndrome and male fertility: PCR-derived fingerprinting, serological and andrological investigations. Clin. Genet. 46: 324-326.